WIZE | Jotup

WIZE Solutions Positioned for Growth with Expanded Resources and Capabilities

Retrieved on:

Monday, March 11, 2024

Other Manufacturing, Commercial Building & Real Estate, Construction & Property, Transport, Manufacturing, Logistics, Supply Chain Management, Retail, Other Construction & Property, Southern California, Automation, Multimedia, Warehouse, Robotics, WIZE, Growth, Acquisition, Record

Offering its installation and project management solutions to some of the largest warehouse projects nationwide, WIZE Solutions is experiencing growth that is on-pace to set records for the material handling company in 2024, including its expansion into the automation sector.

Key Points:

Offering its installation and project management solutions to some of the largest warehouse projects nationwide, WIZE Solutions is experiencing growth that is on-pace to set records for the material handling company in 2024, including its expansion into the automation sector.
Since recent strategic investments and acquisitions, WIZE has grown from 175 employees in July of 2023 to 315 employees today with key personnel additions in sales, operations and installation teams.
WIZE recently acquired Warehouse Equipment Contractors, Inc. and its employee installation teams across the US.
This acquisition will provide WIZE with additional experienced teams of employees in the SoCal market, providing excellent service to the newly expanded customer base.

Wize Solutions Acquired Warehouse Equipment Contractors, Inc.

Retrieved on:

Wednesday, July 26, 2023

Other Construction & Property, Commercial Building & Real Estate, Construction & Property, Insurance, WIZE, Warehouse, Multimedia, Monte, OSHA, Acquisition, Knowledge, Safety, Online shopping

Today, Wize Solutions announced the close of its acquisition of the Warehouse Equipment Contractors, Inc. installation business.

Key Points:

Today, Wize Solutions announced the close of its acquisition of the Warehouse Equipment Contractors, Inc. installation business.
Hear the details directly from Wize leadership on the announcement video here: WIZE Acquisition Announcement Video
This press release features multimedia.
“I am glad to welcome Monte and his staff to WIZE,” said Tyson Bigelow, president of Wize Solutions.
WIZE Solutions maintains a great safety record, the WIZE foremen are OSHA 30 trained and general laborers are OSHA 10 trained.

WizeFrog is Bringing a Massive Cryptocurrency Investment Fund Opportunity to its Investors

Retrieved on:

Friday, May 6, 2022

The platform's community will be able to build wealth and several passive income streams due to the crowdfunded project.

Key Points:

The platform's community will be able to build wealth and several passive income streams due to the crowdfunded project.
In addition, the company intends to disperse revenues from high-quality IDOs, early-stage investments, and DeFi opportunities to its members.
Since the platform will be open to everyone, the community will have assured allocations from the top tiers of the greatest launchpads.
WizeFrog is a decentralized crypto investment fund that provides its community with a significant profit-earning opportunity.

Wize Pharma's Takeover Offer for Cosmos Capital Declared Unconditional

Retrieved on:

Tuesday, February 16, 2021

Mergers and acquisitions, Corporate finance, WIZE, Takeover, Radio stations, Radio broadcasting

HOD HASHARON, Israel, Feb. 16, 2021 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has declared its previously announced off-market takeover offer ("Offer") for all of the ordinary shares in Cosmos Capital Limited, a leading digital infrastructure provider based in Sydney, Australia ("Cosmos"), free from all of the conditions set out in the Offer and, accordingly, the Offer has become unconditional.

Key Points:

HOD HASHARON, Israel, Feb. 16, 2021 /PRNewswire/ -- Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has declared its previously announced off-market takeover offer ("Offer") for all of the ordinary shares in Cosmos Capital Limited, a leading digital infrastructure provider based in Sydney, Australia ("Cosmos"), free from all of the conditions set out in the Offer and, accordingly, the Offer has become unconditional.
The Offer will currently remain open for acceptance until 7.00pm (Sydney time) on March 11, 2021 (but Wize may determine to extend such period, even after the BIA Closing, in order to allow additional Cosmos shareholders to accept the Offer).
Wize strongly encourages all remaining Cosmos shareholders to accept the Offer.
Noam Danenberg, CEO of Wize, stated, "We are very pleased that holders of nearly all Cosmos shares have accepted Wize's off-market takeover offer.

EdTech Startup Wize Raises US$3 Million to Enhance the Online Learning Experience for Students

Retrieved on:

Thursday, January 28, 2021

Articles, WIZE, Multimedia, Educational technology

However, it also highlighted the value of Wize's supplemental online learning platform, which builds learning programs that directly match high school and post-secondary course syllabuses.

Key Points:

However, it also highlighted the value of Wize's supplemental online learning platform, which builds learning programs that directly match high school and post-secondary course syllabuses.
Sure, it's a massive business opportunity, but the Wize experience is entirely focused on empowering the human opportunity."
Ninety-eight percent of Wize's paying customers (2020) indicated studying with Wize improved their grades, and 96% said that using Wize saved them time3.
Education Technology & eLearning Insights, AGC Partners, January 2019
Wize survey of paying customers, September-December 2020
View original content to download multimedia: http://www.prnewswire.com/news-releases/edtech-startup-wize-raises-us3-m...

Wize Pharma Receives Bonus BioGroup Shares from Escrow and Additional Bonus BioGroup Shares Totaling $1.3 Million

Retrieved on:

Monday, January 4, 2021

Finance, WIZE, Escrow, Tel Aviv Stock Exchange, Bonus share, NASDAQ, Money, Financial markets

Wize and Bonus had entered into a strategic transaction in January 2020, whereby, among other things, Bonus had issued to Wize new ordinary shares of Bonus and placed additional Bonus shares in escrow together with funds invested by Wize, which shares and funds were to be released pending, among other things, an uplisting of Bonus to Nasdaq (the "Nasdaq Milestone").

Key Points:

Wize and Bonus had entered into a strategic transaction in January 2020, whereby, among other things, Bonus had issued to Wize new ordinary shares of Bonus and placed additional Bonus shares in escrow together with funds invested by Wize, which shares and funds were to be released pending, among other things, an uplisting of Bonus to Nasdaq (the "Nasdaq Milestone").
According to the Addendum, Wize has agreed to amend certain provisions in the original transaction, including waiving the Nasdaq Milestone, such that the Bonus shares and funds were released from escrow to Wize and Bonus, respectively.
In consideration, Wize received, among other things, 2,987,100 of additional Bonus shares that, together with the 5,682,600 Bonus shares released to Wize from escrow, are worth approximately $1.3 million, based on the US$ equivalent of the closing sale price of Bonus shares on the TASE (NIS 48.4 per Bonus share) on December 31, 2020.
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including dry eye syndrome (DES).

Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement

Retrieved on:

Wednesday, December 30, 2020

Payment systems, Bitcoin, Currency, Cryptocurrencies, WIZE, Exonumia

"We are excited about the Wize Cosmos transaction,"stated Noam Danenberg, CEO of Wize.

Key Points:

"We are excited about the Wize Cosmos transaction,"stated Noam Danenberg, CEO of Wize.
"The Cosmos team brings a proven track record, experienced management and logistics capabilities within the Bitcoin mining industry.
Upon completion of the transaction, pre-closing Wize securityholders will receive one contingent value right ("CVR") for each share of Wize held on the record date.
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including DES.

WIZE ONLINE TUTORING PLATFORM IS NOW FREE SUPPORTING STUDENTS IMPACTED BY COVID-19 CRISIS

Retrieved on:

Tuesday, March 31, 2020

Articles, Education, Learning, Teaching, Tutor, WIZE, Educational technology, Virtual learning environment

Likewise, students, parents and educators are turning to online resources to make the most out of this semester.

Key Points:

Likewise, students, parents and educators are turning to online resources to make the most out of this semester.
Additionally, Wize has curated a pool of qualified tutors over the past12 years and paired them with a state-of-the-art ed-tech platform to bring students an online learning experience like no other.
The online platform also serves as a marketplace for students and parents to find Wize-certified tutors who meet the needs of each individual college student.
Founded in 2017, Wize ( Wizedemy.com ) helps first-year college and university students study with prep courses taught by expert tutors through a highly advanced and easy-to-use online learning platform.

Wize Pharma Lenders Convert $760,000 of Loans Into Equity

Retrieved on:

Tuesday, December 3, 2019

WIZE, Loans

Additionally, Wize has agreed to issue two warrants for each share of common stock issued to the lenders.

Key Points:

Additionally, Wize has agreed to issue two warrants for each share of common stock issued to the lenders.
"We are very pleased with our lenders having exercised part of their loans into equity expressing the faith in the company and facilitating the resources to continue our ongoing clinical program," stated Wize's CEO Noam Danenberg.
"We are eager to move forward with a clean balance sheet that has no remaining convertible loans."
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including DES.

Wize Pharma Enters Exclusive License Agreement for Ophthalmic Non-viral Gene Therapy Technology

Retrieved on:

Monday, September 9, 2019

Branches of biology, Articles, Life sciences, Bioethics, Biotechnology, Gene therapy, Molecular biology, WIZE, Therapy, Medicine

We are very excited to advance our ophthalmic indications into the clinic with Wize Pharma."

Key Points:

We are very excited to advance our ophthalmic indications into the clinic with Wize Pharma."
of Science and Medical Affairs of Copernicus, will prepare the planned clinical trials for the ophthalmic gene therapies licensed to Wize.
Wize believes that gene therapy has reached an inflection point, marked by several high-profile acquisitions over the past 18 months.
Wize and Copernicus intend to also discuss (i) a potential future extension of their collaboration into other gene therapy ophthalmic indications based on Copernicus' gene therapy technology and (ii) other potential strategic transactions.